Cargando…

WHSC1L1-mediated EGFR mono-methylation enhances the cytoplasmic and nuclear oncogenic activity of EGFR in head and neck cancer

While multiple post-translational modifications have been reported to regulate the function of epidermal growth factor receptor (EGFR), the effect of protein methylation on its function has not been well characterized. In this study, we show that WHSC1L1 mono-methylates lysine 721 in the tyrosine ki...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saloura, Vassiliki, Vougiouklakis, Theodore, Zewde, Makda, Deng, Xiaolan, Kiyotani, Kazuma, Park, Jae-Hyun, Matsuo, Yo, Lingen, Mark, Suzuki, Takehiro, Dohmae, Naoshi, Hamamoto, Ryuji, Nakamura, Yusuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5244396/ https://www.ncbi.nlm.nih.gov/pubmed/28102297 http://dx.doi.org/10.1038/srep40664

Ejemplares similares

WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2016)

WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2020)

SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells
por: Vougiouklakis, Theodore, et al.
Publicado: (2015)

Critical roles of SMYD2-mediated β-catenin methylation for nuclear translocation and activation of Wnt signaling
por: Deng, Xiaolan, et al.
Publicado: (2017)

Effects of SMYD2‐mediated EML4‐ALK methylation on the signaling pathway and growth in non‐small‐cell lung cancer cells
por: Wang, Rui, et al.
Publicado: (2017)

PRMT6 increases cytoplasmic localization of p21(CDKN1A) in cancer cells through arginine methylation and makes more resistant to cytotoxic agents
por: Nakakido, Makoto, et al.
Publicado: (2015)

Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX
por: Vougiouklakis, Theodore, et al.
Publicado: (2018)

Protein lysine methyltransferase SMYD3 is involved in tumorigenesis through regulation of HER2 homodimerization
por: Yoshioka, Yuichiro, et al.
Publicado: (2017)

Protein methyltransferases and demethylases dictate CD8+ T-cell exclusion in squamous cell carcinoma of the head and neck
por: Vougiouklakis, Theodore, et al.
Publicado: (2017)

Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteins
por: Piao, Lianhua, et al.
Publicado: (2016)

SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1
por: Yoshioka, Yuichiro, et al.
Publicado: (2016)

SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells
por: Piao, Lianhua, et al.
Publicado: (2015)

Dysregulation of AKT Pathway by SMYD2-Mediated Lysine Methylation on PTEN()()
por: Nakakido, Makoto, et al.
Publicado: (2015)

Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
por: Tanzawa, Shigeru, et al.
Publicado: (2019)

PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP
por: Deng, Xiaolan, et al.
Publicado: (2015)

Clinicopathologic significance of protein lysine methyltransferases in cancer
por: Vougiouklakis, Theodore, et al.
Publicado: (2020)

In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
por: Morishita, Masayo, et al.
Publicado: (2014)

The role of protein methyltransferases as potential novel therapeutic targets in squamous cell carcinoma of the head and neck
por: Saloura, Vassiliki, et al.
Publicado: (2018)

p53-independent p21 induction by MELK inhibition
por: Matsuda, Tatsuo, et al.
Publicado: (2017)

WHSC1 acts as a prognostic indicator and functions as an oncogene in cervical cancer
por: Wu, Jin, et al.
Publicado: (2019)

The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation
por: Kojima, Machiko, et al.
Publicado: (2019)

Identification of a peptide inhibitor for the histone methyltransferase WHSC1
por: Morrison, Michael J., et al.
Publicado: (2018)

TOPK (T‐LAK cell‐originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
por: Park, Jae‐Hyun, et al.
Publicado: (2017)

CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
por: PINTO, Thiago David Alves, et al.
Publicado: (2021)

WHSC1/NSD2 regulates immune infiltration in prostate cancer
por: Want, Muzamil Y, et al.
Publicado: (2021)

Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer
por: Want, Muzamil Y., et al.
Publicado: (2021)

Higher nuclear EGFR expression is a better predictor of survival in rectal cancer patients following neoadjuvant chemoradiotherapy than cytoplasmic EGFR expression
por: Yang, Ching-Chieh, et al.
Publicado: (2019)

Association of EGFR Exon 19 Deletion and EGFR-TKI Treatment Duration with Frequency of T790M Mutation in EGFR-Mutant Lung Cancer Patients
por: Matsuo, Norikazu, et al.
Publicado: (2016)

Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells
por: Kato, Taigo, et al.
Publicado: (2018)

Pulmonary pleomorphic carcinoma: A case harboring EGFR mutation treated with EGFR‐TKIs
por: Masuda, Ken, et al.
Publicado: (2018)

Microsecond-timescale MD simulation of EGFR minor mutation predicts the structural flexibility of EGFR kinase core that reflects EGFR inhibitor sensitivity
por: Yoshizawa, Takahiro, et al.
Publicado: (2021)

Cytoplasmic Chaperones Enhance Soluble Expression of Anti-EGFR huscFv in Escherichia coli
por: Nazari, Atefeh, et al.
Publicado: (2020)

Identification of neoantigen-specific T cells and their targets: implications for immunotherapy of head and neck squamous cell carcinoma
por: Ren, Lili, et al.
Publicado: (2019)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma
por: Pu, Yeong-Shiau, et al.
Publicado: (2009)

TIP30 loss enhances cytoplasmic and nuclear EGFR signaling and promotes lung adenocarcinogenesis in mice
por: Li, Aimin, et al.
Publicado: (2012)

GGA2 interacts with EGFR cytoplasmic domain to stabilize the receptor expression and promote cell growth
por: Uemura, Takefumi, et al.
Publicado: (2018)

Epigenetic Modifiers as Novel Therapeutic Targets and a Systematic Review of Clinical Studies Investigating Epigenetic Inhibitors in Head and Neck Cancer
por: Burkitt, Kyunghee, et al.
Publicado: (2021)

Understanding the Roles of the NSD Protein Methyltransferases in Head and Neck Squamous Cell Carcinoma
por: Murali, Madhavi, et al.
Publicado: (2022)

Recruitment of hexahydroquinoline as anticancer scaffold targeting inhibition of wild and mutants EGFR (EGFR(WT), EGFR(T790M), and EGFR(L858R))
por: Abo Al-Hamd, Mahmoud G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_039c5orlsk0sn4gjhoggiielta